ClinConnect ClinConnect Logo
Search / Trial NCT06619964

Developing Evidence to Inform Regulatory Policy on Nicotine Content in E-Liquids

Launched by ROCHESTER INSTITUTE OF TECHNOLOGY · Sep 28, 2024

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

Electronic Cigarettes Nicotine Addiction Eliquid Nicotine Concentration Perception Of Risk Health Effects Biomarkers Of Exposure Subjective Affect

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 21 yrs or older
  • Pod-style or pen-style users, not adjustable for power or airflow, nicotine greater than 0 mg/mL
  • Current everyday users
  • Use history of at least 30 days
  • No current use of combustible tobacco product, or nicotine replacement therapy
  • CO less than 6 ppm at intake
  • No plans to quit tobacco use in the next 30 days
  • Exclusion Criteria:
  • History of acute or chronic asthma
  • Previous diagnosis of cancer
  • Other chronic medical conditions
  • Use of chronic prescription medications
  • Pneumonia in prior six weeks
  • Upper respiratory tract infection or other febrile illness in previous 2 weeks
  • On antioxidants or anti-inflammatory therapy
  • Pregnant women or women who intend to become pregnant

About Rochester Institute Of Technology

The Rochester Institute of Technology (RIT) is a leading institution dedicated to advancing innovation and research in various fields, including healthcare and technology. With a strong emphasis on interdisciplinary collaboration, RIT conducts clinical trials that leverage its expertise in applied science, engineering, and health informatics. The institute aims to translate research findings into practical applications that improve patient outcomes and enhance healthcare delivery. Committed to ethical standards and rigorous methodologies, RIT's clinical trials contribute to the advancement of medical knowledge and the development of novel therapeutic strategies.

Locations

Rochester, New York, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported